Health Care Market News " Resverlogix (TSX:RVX) partners with EVERSANA to launch COVID-19 treatment Resverlogix (RVX) has partnered with EVERSANA to launch Apabetalone for COVID-19 in the United States and Canada. Trevor Abes2 mins03 June 2021 13:15 (EDT)
